An Overview of Pediatric Pulmonary Complications During COVID-19 Pandemic: A Lesson for Future
- PMID: 39508631
- PMCID: PMC11542302
- DOI: 10.1002/iid3.70049
An Overview of Pediatric Pulmonary Complications During COVID-19 Pandemic: A Lesson for Future
Abstract
Background: The pediatric community is considered a suitable target for controlling the spread and mortality of viral diseases. In late December 2019, a respiratory disease due to the novel coronavirus, later COVID-19, hit the globe. The COVID-19 global disruption had direct and indirect impacts on different aspects of child health. Therefore, surveillance, preventive approaches, and treatment plans for children came into the spotlight.
Objective: This study aims to discuss the clinical pictures as well as laboratory and radiological findings of the infected children during the COVID-19 pandemic. The focus of this study is to express the clinical manifestations of respiratory disease in pediatric SARS-CoV-2, available therapeutic options, vaccine recommendations, and long COVID sequelae in affected children. This review could serve as a hint for upcoming challenges in pediatric care during future pandemics.
Results: The clinical presentation of COVID-19 in pediatrics can range from mild pulmonary disease to acute respiratory distress syndrome (ARDS). Supportive care is a crucial component of the management of pediatric COVID-19. However, the importance of specializing in how to treat patients with more severe conditions cannot be overstated. Additionally, clinicians must consider prevention strategies as well as potential complications.
Conclusion: Although the infected patients are dipping day by day, there is a lack of clinical guidelines for pediatric SARS-CoV-2-associated pulmonary diseases. Understanding of the physicians about all aspects of pediatric care during the COVID-19 pandemic could lead to enhanced quality of future patient care and safety, reduced costs of health policies, and surveil the risk that patients with respiratory viruses can expose to society.
Keywords: COVID‐19; SARS‐CoV‐2; corona virus; long COVID; pandemic; pediatrics; pulmonary; respiratory complications; viral infection.
© 2024 The Author(s). Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Human and novel coronavirus infections in children: a review.Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25. Paediatr Int Child Health. 2021. PMID: 32584199 Review.
-
Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.Front Immunol. 2020 May 12;11:1022. doi: 10.3389/fimmu.2020.01022. eCollection 2020. Front Immunol. 2020. PMID: 32574260 Free PMC article. Review.
-
SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.Int Rev Immunol. 2023;42(6):393-414. doi: 10.1080/08830185.2022.2079642. Epub 2022 May 28. Int Rev Immunol. 2023. PMID: 35635216 Review.
-
COVID-19 and ARDS: Update on Preventive and Therapeutic Venues.Curr Mol Med. 2022;22(4):312-324. doi: 10.2174/1566524021666210408103921. Curr Mol Med. 2022. PMID: 33829971 Review.
-
COVID-19 PICU guidelines: for high- and limited-resource settings.Pediatr Res. 2020 Nov;88(5):705-716. doi: 10.1038/s41390-020-1053-9. Epub 2020 Jul 7. Pediatr Res. 2020. PMID: 32634818 Free PMC article.
References
-
- Wang L., Davis P. B., Berger N., Kaelber D. C., Volkow N., and Xu R., “Association of COVID‐19 With Respiratory Syncytial Virus (RSV) Infections in Children Aged 0–5 Years in the USA in 2022: A Multicentre Retrospective Cohort Study,” Family Medicine and Community Health 11, no. 4 (2023): e002456. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous